 In this research study, the investigators are looking to determine the effectiveness of Pembrolizumab MK-3475 when given with bevacizumab or when given alone for the treatment of recurrent glioblastoma multiforme GBM. This study will also test the safety and tolerability of Pembrolizumab MK-3475 when given alone or with bevacizumab. 